Systemic sclerosis can scar organs and damage joints. Roche said in a statement that it has the highest mortality rate of any rheumatic disease.

The Breakthrough Therapy designation speeds drugs through the FDA review process and is applied to drugs that appear to offer a significant benefit over treatments that are currently on the market or that treat serious diseases for which no treatment is available.